Sukhatme Mayukh

President & CIO, DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Feb 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9.0M
Net Open-Market Flow
-$9.0M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Sell(S)339K$26.47$9.0M19.1M
Feb 9, 2026Option exercise(M)652K$12.68$8.3M19.5M
Feb 9, 2026Other(J)312K$26.47$8.3M18.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Option exercise(M)652K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001635088-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: